Results 221 to 230 of about 116,257 (347)

Pharmacodynamic individualization of phage therapy against a KPC-5-producing <i>Pseudomonas aeruginosa</i>. [PDF]

JAC Antimicrob Resist
Nguyen TD, Sanborn JT, Ho BM, Luong T, Wood TD, Chen L, Roach DR, Smith NM.   +7 more
europepmc   +1 more source

Bismuth Bicycles

Journal of Peptide Science, Volume 32, Issue 3, March 2026.
Discovery, evolution and potential future applications of bismuth bicycle molecules—a novel class of therapeutics with unique properties. ABSTRACT Bicyclic peptides are emerging as next generation therapeutics by combining the affinity and specificity of antibodies with the synthetic convenience of small molecules.
Saan Voss, Amin Sagar, Arnaud Tiberghien, Richard J. L. Hughes, Liuhong Chen, Inmaculada Rioja, Mark Frigerio, Michael J. Skynner, David R. Spring   +8 more
wiley   +1 more source

Phage therapy as a revitalized weapon for treating clinical diseases. [PDF]

Microbiome Res Rep
Wang Y, Yu Y.
europepmc   +1 more source

Studies in vitro and in vivo of phage therapy medical products (PTMPs) Targeting Clinical Strains of Klebsiella pneumoniae belonging to the clone ST512

Inés Bleriot, Lucía Blasco, Patricia Fernández-Grela, Laura Fernández‐García, Lucía Armán, Clara Ibarguren, Concha Ortiz-Cartagena, Antonio Barrio-Pujante, José Ramón Paño Pardo, Jesús Oteo, María Tomás   +10 more
openalex   +1 more source

Integrated scFv identification and CAR T cell generation for AML targeting in vivo

International Journal of Cancer, Volume 158, Issue 4, Page 994-1007, 15 February 2026.
What's new? Acute myeloid leukemia (AML) is a rapidly progressing blood cancer. Advancing chimeric antigen receptor (CAR) T cell therapies, particularly through rapid translation of single chain variable fragment (scFv) discovery into CAR constructs, may improve clinical outcomes, especially the development of patient individualized CAR T cells.
Yi Liu, Annika Lauk, David Sedloev, Josephine Brysting, Ela Cetin, Chunan Liu, Maximilian Mönnig, Thomas Luft, Haiyang Yun, Michael Schmitt, Tim Sauer, Fengbiao Zhou, Christian Rohde, Carsten Müller‐Tidow   +13 more
wiley   +1 more source

Phage therapy for intestinal infections: efficacy, challenges, and future directions in translational research. [PDF]

Front Microbiol
Wang X, Li J, Ge Z, Fan J, Ma D, Cao H, Shen J, Wang Y, Liu Z, Gomaa SE, Li X, Ji X, Teng T.   +12 more
europepmc   +1 more source

Analysis of Pro- and Anti-Inflammatory Gene Response Patterns in Patients Receiving Phage Therapy. [PDF]

Int J Mol Sci
Kasprzak H, Przybylski M, Fortuna W, Letkiewicz S, Rogóż P, Bubak B, Górski A, Międzybrodzki R.   +7 more
europepmc   +1 more source

Comprehensive Review on Phage Therapy and Phage-Based Drug Development

Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga, Kotaro Kiga, Teppei Sasahara, Yoshifumi Aiba, Xin-Ee Tan, Srivani Veeranarayanan, Kanate Thitiananpakorn, Huong Minh Nguyen, Dhammika Leshan Wannigama   +10 more
openalex   +2 more sources

Phage Therapy Against Antibiotic‐Resistant and Multidrug‐Resistant Infections Involving Nonhealing Wounds and Prosthetic Joint Infections Associated With Biofilms: A Mini‐Review [PDF]

Kashif Haq, Martin Figgitt, David Lee
openalex   +1 more source

Broth Optical Density-Based Assessment for Phage Therapy: Turbidity Reduction, Antibacterial Virulence, and Time-Kill. [PDF]

Viruses
Abedon ST.
europepmc   +1 more source